Skip to content
← Full study record

NCT00064298 · OUTCOME

Cell Proliferation (Ki-67) at Baseline and Week 12

Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer · Source last updated 2021-09-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
percentage of cells
Interval / dispersion
Standard Error
Time frame
baseline and 12 weeks

What was measured

Cell proliferation (Ki-67) at baseline and week 12. Ki67 is a cell proliferation associated nuclear protein. It is measured continuously. Higher values are worse.

Analysis population: All participants randomized. Not all participants had p27 or Ki67 data so the sample sizes for the primary and secondary analyses differ from the overall sample size.

Groups in this outcome

Arm I - JuicePlus

Patients receive oral fruit and vegetable extracts twice daily. fruit and vegetable extracts: Given orally

Arm II - Control

Patients receive oral placebo twice daily. placebo: Given orally

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Arm I - JuicePlus72
Arm II - Control62

Reported measurements

Baseline

Analysis denominator · Participants

GroupSource count
Arm I - JuicePlus45
Arm II - Control42
Values in percentage of cells · Interval/dispersion: Standard Error
GroupValueSpreadLowerUpperComment
Arm I - JuicePlus26.81.20Not reportedNot reportedNot reported
Arm II - Control26.21.28Not reportedNot reportedNot reported
12 Weeks

Analysis denominator · Participants

GroupSource count
Arm I - JuicePlus47
Arm II - Control40
Values in percentage of cells · Interval/dispersion: Standard Error
GroupValueSpreadLowerUpperComment
Arm I - JuicePlus27.11.43Not reportedNot reportedNot reported
Arm II - Control27.01.55Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        1.20
        value
        26.8
      2. group Id
        OG001
        spread
        1.28
        value
        26.2
    denoms
    1. counts
      1. group Id
        OG000
        value
        45
      2. group Id
        OG001
        value
        42
      units
      Participants
    title
    Baseline
  2. categories
    1. measurements
      1. group Id
        OG000
        spread
        1.43
        value
        27.1
      2. group Id
        OG001
        spread
        1.55
        value
        27.0
    denoms
    1. counts
      1. group Id
        OG000
        value
        47
      2. group Id
        OG001
        value
        40
      units
      Participants
    title
    12 Weeks
denoms
  1. counts
    1. group Id
      OG000
      value
      72
    2. group Id
      OG001
      value
      62
    units
    Participants
description
Cell proliferation (Ki-67) at baseline and week 12. Ki67 is a cell proliferation associated nuclear protein. It is measured continuously. Higher values are worse.
dispersion Type
Standard Error
groups
  1. description
    Patients receive oral fruit and vegetable extracts twice daily. fruit and vegetable extracts: Given orally
    id
    OG000
    title
    Arm I - JuicePlus
  2. description
    Patients receive oral placebo twice daily. placebo: Given orally
    id
    OG001
    title
    Arm II - Control
param Type
MEAN
population Description
All participants randomized. Not all participants had p27 or Ki67 data so the sample sizes for the primary and secondary analyses differ from the overall sample size.
reporting Status
POSTED
time Frame
baseline and 12 weeks
title
Cell Proliferation (Ki-67) at Baseline and Week 12
type
SECONDARY
unit Of Measure
percentage of cells

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice